Australia markets closed

AIM ImmunoTech Inc. (AIM)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
0.4048+0.0079 (+1.99%)
As of 09:58AM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-20,902
-19,445
-19,127
-14,400
-9,404
Depreciation & amortisation
280
256
775
733
792
Deferred income taxes
-2,526
197
-2,319
-96
-129
Stock-based compensation
1,040
954
1,568
1,036
853
Change in working capital
3,736
966
895
605
-543
Accounts receivable
28
0
34
40
191
Accounts payable
587
179
-185
-89
-207
Other working capital
-16,035
-16,379
-14,598
-10,963
-9,432
Other non-cash items
-3,423
-680
2,778
85
255
Net cash provided by operating activities
-15,784
-16,108
-13,965
-10,368
-9,067
Cash flows from investing activities
Investments in property, plant and equipment
-251
-271
-633
-595
-365
Purchases of investments
-22,585
-2,724
-22,535
-18,613
-5,782
Sales/maturities of investments
30,525
10,083
22,292
10,044
0
Net cash used for investing activities
7,989
10,988
-631
-9,164
-6,147
Cash flows from financing activities
Debt repayment
0
0
-4,854
-4,685
-2,550
Common stock issued
205
80
13,042
61,248
15,303
Net cash used provided by (used for) financing activities
205
80
8,188
56,563
16,385
Net change in cash
-7,590
-5,040
-6,408
37,031
1,171
Cash at beginning of period
37,349
32,093
38,501
1,470
299
Cash at end of period
29,759
27,053
32,093
38,501
1,470
Free cash flow
Operating cash flow
-15,784
-16,108
-13,965
-10,368
-9,067
Capital expenditure
-251
-271
-633
-595
-365
Free cash flow
-16,035
-16,379
-14,598
-10,963
-9,432